Key Takeaways The CATNON trial showed adjuvant Temodar benefits grade 3 glioma patients, with no added benefit from concurrent chemotherapy, reducing potential toxicity. HER3-DXd, an antibody-drug ...

Non-small cell lung cancer (NSCLC) develops in lung tissues, but when it's metastatic, it has spread to distant areas of the ...

Compared with whole brain radiation, stereotactic radiation reduces the rates of neurologic deaths in patients with SCLC and ...

Presentations to include updated and additional Phase 2 clinical data for recently FDA-approved IBTROZI Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughe ...

Of 1281 patients with brain metastases from non-GI cancers, most (54.7%) had lung cancer, followed by breast (14.7%) and genitourinary (7.9%) cancers.

While metastatic lung cancer can rarely be cured, improvements in the detection and treatment of brain metastases are allowing people to live longer, with a higher quality of life.

Given the growing interest PDL-1’s role in cancer progression, it is important to assess if expressing PDL1 and to what degree, is related to the progression and development of brain metastasis in ...

2. Three Fractionated SRS Treatments Versus One MSK is a participating institution in a large, phase 3 trial testing fractionated SRS versus standard SRS in patients with intact brain metastases ...

Study Identifies Clinicopathologic and Genomic Features Associated With Brain Metastasis After Lung Cancer Resection MSK researchers evaluated features associated with brain metastasis in a ...